Eiger BioPharmaceuticals, Inc. (EIGR)

NASDAQ: EIGR · IEX Real-Time Price · USD
9.29
+0.60 (6.90%)
Aug 10, 2022 4:00 PM EDT - Market closed

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year 2021202020192018201720162015201420132012 2011
Revenue
12.14000000000
Upgrade
Cost of Revenue
0.75000000000
Upgrade
Gross Profit
11.4000000000
Upgrade
Selling, General & Admin
23.920.5617.1113.961213.114.860.873.042.63
Upgrade
Research & Development
64.4441.5951.7937.0929.5233.018.120.6416.9313.31
Upgrade
Operating Expenses
88.3462.1568.951.0541.5246.1212.971.5219.9615.95
Upgrade
Operating Income
-76.94-62.15-68.9-51.05-41.52-46.12-12.97-1.52-19.96-15.95
Upgrade
Interest Expense / Income
3.563.593.412.331.520.690.3500.060.11
Upgrade
Other Expense / Income
-46.65-0.69-2.06-0.99-0.60.2800-0.03-0.34
Upgrade
Pretax Income
-33.85-65.05-70.25-52.39-42.45-47.09-13.32-1.52-20-15.72
Upgrade
Income Tax
0.06000000000
Upgrade
Net Income
-33.92-65.05-70.25-52.39-42.45-47.09-13.32-1.52-20-15.72
Upgrade
Preferred Dividends
000000000.860.34
Upgrade
Net Income Common
-33.92-65.05-70.25-52.39-42.45-47.09-13.32-1.52-23.96-16.21
Upgrade
Shares Outstanding (Basic)
34282314960000
Upgrade
Shares Outstanding (Diluted)
34282314960000
Upgrade
Shares Change
20.61%23.51%67.12%56.21%45.30%2704.03%10.51%228.87%7.57%31946.20%
Upgrade
EPS (Basic)
-1.00-2.31-3.08-3.84-4.86-7.84-62.19-7.82-406.41-295.95
Upgrade
EPS (Diluted)
-1.00-2.31-3.08-3.84-4.86-7.84-62.19-7.82-406.41-295.95
Upgrade
Free Cash Flow Per Share
-2.10-2.25-2.81-3.14-4.40-6.33-42.85-6.62-276.24-267.98
Upgrade
Gross Margin
93.86%---------
Upgrade
Operating Margin
-633.66%---------
Upgrade
Profit Margin
-279.34%---------
Upgrade
Free Cash Flow Margin
-587.10%---------
Upgrade
Effective Tax Rate
-0.19%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Upgrade
EBITDA
-29.5-60.81-66.36-50.01-40.88-46.37-12.96-1.51-19.87-15.55
Upgrade
EBITDA Margin
-242.92%---------
Upgrade
Depreciation & Amortization
0.80.650.490.050.040.020.010.010.070.06
Upgrade
EBIT
-30.29-61.46-66.85-50.06-40.92-46.4-12.97-1.52-19.94-15.61
Upgrade
EBIT Margin
-249.50%---------
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).